<DOC>
	<DOCNO>NCT02215720</DOCNO>
	<brief_summary>Cetuximab EGFR inhibitor show efficacy alone combination colorectal cancer head neck cancer several phase II/III study . Temsirolimus new mTOR inhibitor show interesting result several Phase I/II study advance kidney cancer bad prognosis . Study hypothesis combination two compound inhibition two pathway time efficiency tumoral growth inhibition pathways isolation .</brief_summary>
	<brief_title>Temsirolimus Cetuximab Patients With Advanced Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Cetuximab</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients malignant tumor confirm histologically cytologically respond usual therapeutic curative treatment Age &gt; /= 18 year ECOG 0 1 Life expectancy &gt; /= 12 week Grade &lt; /=1 adverse effect relate previous therapy surgery ( except alopecia ) Appropriate organic function define : ASAT ALAT &lt; /= 2.5xLSN ASAT ALAT &lt; /= 5xLSN case inappropriate hepatic function due underlie disease Bilirubin &lt; /= 1.5xLSN Albumin &gt; /= 3.0 g/dL Neutrophil count ( PNN ) &gt; /= 1 500/mL Platelets &gt; /= 100 000/mL Hemoglobin &gt; /= 9.0 g/dL Creatinin &lt; /= 1.5xLSN Cooperative patient able respect protocol Treatment chemotherapy , radiotherapy , surgery two compound study within 4 week inclusion Previous treatment association mTOR inhibitor EGFR inhibitor Diagnosis secondary cancer within last 3 year except basalcell carcinoma , cutaneous spinocellular cancer situ carcinoma well treat Grade &gt; /= 2 nephropathy accord NCI CTCAE Current treatment curative dose coumadin heparin low molecular weight Previous uncontrolled brain metastasis , medullar compression carcinomatosis meningitis proof leptomeningeal pathology metastasis . Presence one og pathology last 12 month inclusion : myocardial infarction angina pectoris bypass coronal peripheral artery heart failure stroke cerebral bleeding pulmonary embolism Grade 3 bleed accord NCI CTCAE criterion less 3 week treatment start Uncontrolled high blood pressure ( &gt; 150/100mhHg ) Grade &gt; /=2 heart rate disorder , atrial fibrillation whichever grade , lengthen QTC &gt; 450 msec male &gt; 470 msec female . Patients HIV positive Pregnant breastfeed woman Patients psychiatric disorder Active alcoholism Previous pulmonary interstitial disease Previous hypersensitivity antihistamine treatment and/or medical contraindication antihistamine corticoid treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>